As part of our ongoing series focussing on new registrations in Australia, we have added a product review of the efficacy and tolerability of 4% fluorouracil once daily in the treatment of patients with actinic keratosis.
This review discusses current treatment of actinic keratosis, mechanism of action of fluorouracil, dosage and administration and key clinical trials. It also provides commentary and recommendations from Professor Stephen Shumack, Clinical Associate Professor, Department of Dermatology at the University of Sydney, and Senior Staff Specialist at the Royal North Shore hospital of Sydney.
Please login below to download this issue (PDF)